Will a Brain Cancer Vaccine Be Available Soon?

Brain cancer is one of the most aggressive of all. However, a vaccine that’s already developed may spell the end for this disease. Will a brain cancer vaccine be available soon?
Will a Brain Cancer Vaccine Be Available Soon?

Last update: 30 July, 2020

Vaccines are good ways to prevent and cure diseases. Thus, it’s quite understandable why researchers are looking for different ways of putting an end to cancers as aggressive as brain cancer. But what if there’s already a brain cancer vaccine?

A brain cancer diagnosis is a serious blow not only for patients, but also for their families. The depression diagnosed patients sometimes fall into, as the article Quality of life in patients with gliomas: The role of psychological variables states, causes anxiety and great discomfort.

But perhaps there’s light at the end of the tunnel. This is because several sources inform us that a vaccine could be the definitive solution for brain cancer. Below, discover the expectations and how this vaccine will work to eradicate the disease.

Brain cancer vaccine

The newspaper El País published a story in December 2018 that spoke about personalized vaccines for patients who were suffering from brain cancer. It was developed in a study with a few participants that reported quite encouraging results.

However, because the number of participants was quite low, the researchers don’t dare to affirm that they’ve found the cure to this type of cancer. Thus, researchers need to conduct further studies to ensure the veracity of the evidence.

Brain cancer vaccine.
Currently, there are new avenues of research toward developing a cancer vaccine.


Immunotherapy is a highly relevant concept in this vaccine that experts recently discovered. This term refers to the use of the body’s own defenses to direct and attack brain cancer.

However, the researchers discovered that not all tumors are exactly the same and neither do they all respond well to immunotherapy treatment. For this reason, “precision immunotherapy” has been worked on to treat patients who suffer from glioblastoma.

This article may interest you: Brain Metastases: Description and Treatment

Personalized vaccine

Glioblastoma is one of the cancers with the worst prognosis. Therefore, patients who suffered it at the time of the study needed a personalized vaccine to ensure favorable results. But how do experts do this?

The best way is to design a vaccine with the antigens of the patient’s own tumor. This favors a much more effective immune response. The lymphocytes manage to recognize “bad” cells and destroy them.

In the investigation, they discovered that the patients responded favorably to the personalized vaccine and not to the generic one. Thus, a generic one for any type of tumor doesn’t work. To end brain cancer, the vaccine must be personalized.

Read this article to learn more: First Signs of Cancer That 90% of People Ignore

Expectations for brain cancer

Scientists holding vaccines.
Although there’s still a long way ahead, experts are beginning to pave the way to safer and more effective therapies.

The advances that experts are making in different types of cancer, and specifically brain cancer, are quite encouraging. However, only 30 people participated in the study we mentioned in this article.

This may also make you wonder if it would be feasible to study and create a personalized vaccine for each person who has brain cancer. Is this feasible? Would people be able to afford it?

Furthermore, it’s important to mention that the research failed to destroy the cancer of the people who suffered from it. However, it’s important to emphasize that the patients suffered from a quite aggressive type of cancer with a high death rate, despite the treatments that they received.

What it did achieve was increase their life expectancy. According to what the newspaper El País indicated, these patients normally live for 14 months. However, the vaccine allowed this number to rise to 29 months. Undoubtedly, it’s an encouraging number that indicates that experts are on the right track and that, perhaps, the definitive cure is near.

Currently, researchers are continuing to study different possibilities to put an end to these types of diseases that kill thousands of people each year. We hope that, sooner than later, we’ll hear the news about a vaccine that completely eradicates cancer.

Children, adults, and the elderly suffer from different types of cancer. Undergoing chemotherapy and radiotherapy is an experience that we hope will soon have an accessible, reliable, and effective vaccine solution as a solution.

Do you think that cancer will eventually have a cure? Do you think this will also be feasible for more aggressive cancers like glioblastoma?

It might interest you...
Opioid Treatment for Cancer Pain
Step To Health
Read it in Step To Health
Opioid Treatment for Cancer Pain

People with cancer use one or another opioid treatment to deal with their intense pain as it's often intense and disabling and may arise due to a t...

  • Espinosa-Montero, Rubén, Santana, Blanca, Flores-Armas, Eduardo Miguel, & Sadowinski-Pine, Stanislaw. (2009). Astrocitoma pilocítico de cerebelo (K-07-1028) con tumor residual. Boletín médico del Hospital Infantil de México, 66(1), 80-91. Recuperado en 15 de abril de 2019, de http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462009000100009&lng=es&tlng=es.
  • González Trujillo, F., Castro Noriega, C., Castro Ramírez, O. J., Olaya, N., Penagos González, P. J., Zubieta Vega, C., & Melo Gómez, G. (2014). Multiform glioblastomas:<: current discussions on biomolecular markers as factors for prognosis regarding a series of cases with a survival rate over 2 years in the Instituto Nacional de Cancerología INC-Colombia. Acta Neurológica Colombiana, 30(4), 282-289.
  • Pinilla-Arias, D., Mateo-Sierra, O., Gutiérrez, F.A., Fernández-Carballal, C., & Carrillo, R.. (2005). Inmunoterapia en astrocitomas de alto grado: principios y estado actual. Neurocirugía, 16(4), 345-358. Recuperado en 15 de abril de 2019, de http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-14732005000400005&lng=es&tlng=es.